Gilead Details Promising Early COVID Antiviral Data, Setting Up Larger Studies ...Middle East

Medscape - News
Gilead Sciences on Tuesday unveiled data from the first human study of its experimental oral COVID-19 antiviral, saying the results in healthy volunteers cleared the way for two large Phase III trials. Reuters Health Information

Read More Details
Finally We wish PressBee provided you with enough information of ( Gilead Details Promising Early COVID Antiviral Data, Setting Up Larger Studies )

Apple Storegoogle play

Also on site :